Abstract: A resin composition includes (a) at least one 2-methylene-1,3-dicarbonyl compound, (b) an initiator comprising at least one basic substance, and (c) an anionic polymerization inhibitor including at least one borate ester compound.

Abstract: The polymerization of monomers may be at least partially reduced or inhibited by introducing an effective amount of an additive. The additive may be or include a first compound: where: R1 and R2 may be or include an alkyl group, an aryl group, an alkyl group having a heteroatom, an aryl group having a heteroatom, and combinations thereof. The hetero atom may be or include sulfur, nitrogen and/or oxygen. R1 may be the same or different from R2. The polymerizable monomers may be or include, but are not limited to styrene, butadiene, isoprene, acrylic acid, acrylonitrile, vinyl acetate, and combinations thereof.

Abstract: Novel compounds and pharmaceutical compositions useful as EGFR tyrosine kinase inhibitors. Methods of the invention include administration of the EGFR TK inhibitors to treat diseases characterized by enhanced expression of EGF, including cancers, particularly breast cancer. Additionally, a homology model representing the structure of EGFR kinase domain is provided, which model is useful for the rationally design and screening of compounds predicted to bind favorably to EGFR and to inhibit EGFR TK.

Abstract: An antifoulant composition comprising (meth)acrylic acid and one or more (meth)acrylate or (meth)acrylamide antifoulant polymers and a method of preventing fouling in (meth)acrylic acid processes comprising adding the (meth)acrylate or (meth)acrylamide antifoulant polymers to the (meth)acrylic acid process stream.

Abstract: The present invention relates to the use of phenylenediamines, preferably para-phenylenediamines, in combination with hindered phenols, to reduce polymer formation during the manufacture of acrylonitrile.

Abstract: The present invention relates to the use of phenylenediamines, preferably para-phenylenediamines, in combination with hindered phenols, to reduce polymer formation during the manufacture of acrylonitrile.

Abstract: The present invention relates to the use of phenylenediamines, preferably para-phenylenediamines, in combination with hindered phenols, to reduce polymer formation during the manufacture of acrylonitrile.

Abstract: It has been discovered that the polymerization of unsaturated compounds, such as butadiene, may be inhibited by the addition of a diene and/or alkanolamine inhibitor. The inhibitor is believed to catalytically destroy peroxides present, such as hydrogen peroxide, which may be present in trace amounts. Particularly useful inhibitors include, but are not limited to, ethylenediamine (EDA) and monoethanolamine (MEA).

Abstract: An adhesive composition includes a polymerizable adhesive monomer, at least one vapor phase stabilizer, and at least one liquid phase stabilizer. The combination of at least one vapor phase stabilizer and at least one liquid phase stabilizer provides superior stabilization and shelf-life for the monomer composition. The stabilized adhesive composition provides superior performance and shelf-life and can be sterilized without significant polymerization of the monomer.

Abstract: The present invention provides substituted phenols which are effective to inhibit polymer formation during the manufacture of acrylonitrile. Preferred substituted phenols are (a) hindered phenols, nonhindered phenols, and partially hindered phenols, or (b) combinations of hindered phenols with nonhindered or partially hindered phenols. A most preferred substituted phenol is p-nitrosophenol. In a preferred embodiment, the substituted phenols (with the exception of p-nitrosophenol) are combined with hydrogen transfer agents.

Abstract: Ethylenically unsaturated monomers are protected from premature polymerization during manufacture and storage by the incorporation therein of an effective stabilizing amount of a 7-substituted quinone methide compound.